Researchers have found in a new study that using an age-adjusted D-dimer cutoff can safely rule out deep vein thrombosis and ...
1. Park K-W, Choi B, Moon D-H, Park S-M, Ye Y-M. Serum haptoglobin as a predictor of treatment response in patients with chronic spontaneous urticaria. Clin Trans Allergy. Published online January 7, ...
A new study published in the journal of Frontiers in Nutrition showed that in sepsis patients, vitamin B1 (VB1) levels are ...
To expand undergraduate medical education and attract more physicians to practice in central and southern Delaware, ChristianaCare, Bayhealth and Philadelphia College of Osteopathic Medicine (PCOM) ...
"It was incredibly frightening. I had never felt so close to something life-threatening before," Nikki Bahan, a mom of three, ...
" The CEO pointed to key upcoming events: "Commercial sales progress for REDEMPLO, Q3 2026 readout of Phase III SHASTA-3 and ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q1 2026 Earnings Call Transcript February 5, 2026 Arrowhead Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.22 EPS, expectations ...
Machine learning algorithms that output human-readable equations and design rules are transforming how electrocatalysts for ...
Tu, H. and Huang, Y.Y. (2026) Progress in Quantitative Imaging Assessment of Dermatomyositis-Associated Interstitial Lung ...
Zacks Small Cap Research on MSN
ARWR: Strong Start for REDEMPLO Commercialization…
By David Bautz, PhD NASDAQ:ARWR READ THE FULL ARWR RESEARCH REPORT Business Update First Commercial Sales of REDEMPLO® ...
When the days shorten and the sun sinks low in the sky, that familiar winter slump sets in. There's a fundamental reason for this seasonal fatigue: low levels of vitamin D—the "sunshine vitamin." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results